Hims & Hers Health Inc.

Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer.
Quotes
- Bid
- Ask
- Open
- Previous close
- Volume
- Relative volume
- High
- Low
Returns
Key stats
ESG risk
ESG risk is a measure of how well a company manages material ESG risks. Sustainalytics’ ESG risk category is designed to help investors identify and understand financially material ESG risks at the company level and how they might affect the long-term performance for equity investments. The scale is from 0-100. The lower the risk, the better (0 is equivalent to no risk and 100 the most severe).
Download ESG risk methodology (PDF)Financials
About Hims & Hers Health Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
Hims & Hers Health, Inc. (HIMS) is a US-based telehealth company that provides direct-to-consumer healthcare services and wellness products through a digital platform. Founded in 2017 and headquartered in San Francisco, California, the company connects users with licensed healthcare professionals for treatment in areas such as mental health, dermatology, sexual health, and general wellbeing.
Its platform supports asynchronous and live consultations, with personalised treatment plans and prescriptions delivered directly to patients. The company operates under two consumer brands: Hims (targeted at men) and Hers (targeted at women), offering both subscription-based and one-time purchase options.
Hims & Hers also sells over-the-counter health and personal care products via its website and selected retail partners. Its vertically integrated model combines clinical services, pharmacy operations, and proprietary technology to support scalable, accessible care.
Hims & Hers Health is listed on the New York Stock Exchange (NYSE).
Frequently asked questions
To buy Hims & Hers Health Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Hims & Hers Health Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Hims & Hers Health Inc. is HIMS:xnys. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Hims & Hers Health Inc. has its primary listing on New York Stock Exchange. You can trade Hims & Hers Health Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Hims & Hers Health Inc. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Hims & Hers Health Inc. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Hims & Hers Health Inc. or others.